anemia glutathione reductase deficiency Nineteen-year follow-up of a patient with severe synthetase Inborn errors in the metabolism
Description
The second category included substances considered too risky for compounding
(c) a reticulocyte response to B12 treatment
doi: 10.1210/clinem/dgab429 431 BerwaertsJMoorkensGAbsR
Statistical analyses were conducted using R
Most people tolerate both medication types well after initial adjustment
